Navigating China’s Regulatory Landscape: Devices, Combination Products and Emerging Trends

China’s regulatory framework for medical devices continues to evolve. This webinar will explore the regulatory landscape for medical devices in China, with a particular focus on devices used in combination products. It will provide a high-level overview of the regulatory journey from pre-market submission to post-market compliance, highlighting the unique considerations for device components within drug/device combinations. Emphasizing strategic planning and cross-functional collaboration, the session will highlight how manufacturers can align with regulatory expectations and streamline approval processes. The discussion will also touch on emerging regulatory topics, including China’s implementation of GMP and other developments shaping compliance and market access. Designed for industry professionals, this session provides practical insights to support regulatory planning and decision-making in the China market.